Upload Avatar (500 x 500)
Ying Wang
wangy6@sustech.edu.cn
Chinese, English
Guangdong
Southern University of Science and Technology
Medical School
  • 2008-2012 Bachelor in Pharmaceutical Engineering: Guizhou University
  • 2012-2017 PhD in Cardiovascular Pharmacology: Fudan University
  • Published over ten research papers as first author in the field of cardiology
  • 2017-2022 Postdoctoral Researcher at University of California, Davis
  • 2022-present Associate Professor at Southern University of Science and Technology
  • 2012 Guizhou Province Outstanding Graduate
  • 2012 Fudan University PhD Freshman Scholarship
  • 2013 Fudan University Cross-disciplinary Excellent PhD Student Research Award
  • 2014 9th PharmSci@Asia Forum, Paper Award
  • 2015 Shanghai Pharmacological Society Young Scholar Forum, Excellent Paper Award
  • 2015 Yangtze Delta Region Forum on Life Sciences and Human Health, First Prize
  • 2016 Society for Laboratory Automation and Screening (SLAS) 5th Annual Meeting Tony B. Academic Travel Award
  • 2017 Society for Laboratory Automation and Screening (SLAS) 6th Annual Meeting Tony B. Academic Travel Award
  • 2021 American Heart Association (AHA) Postdoctoral Fellowship
  • 2022 American Heart Association (AHA) Young Scientist Travel Award
GPCR nanodomain regulation of cardiac physiology and pathology
Calcium signaling disorders in heart failure and arrhythmias
Polypharmacology in cardiovascular pharmacology
  • Nuclear β-adrenergic signaling microdomain alleviates diabetic kidney fibrosis by YAP inactivation, Xiang W, Lu H, Shen A, Ni H, Wang Y
  • Nitric oxide synthase isoforms dictate a biased and compartmentalized adrenergic signaling to promote cardiac contractility, Wang Y, Zhao M, Liu XH, Xu B, Rivera G, Xiang YK
  • Phosphodiesterases in heart and vessels- From Physiology to Diseases, Fu Q, Wang Y, Yan C, Xiang YK, 2023
  • HFrEF and HFpEF model-specific remodeling of subcellular PKA signaling at the ryanodine receptors and SERCA2a, Bing Xu, Ying Wang, Chaoqun Zhu, Meimi Zhao, Yu Zhang, Bingqing Deng, Zhenduo Zhu; Qiuyun Guan, Nipavan Chiamvimonvat, Qingtong Wang, and Yang K. Xiang
  • Unveiling Catecholamine Dynamics in Cardiac Health and Disease: Mechanisms, Implications, and Future Perspectives, Wenjing Xiang1*, Xingyun Wang1*, Lei Li1, Junhui Zeng1, Haocheng Lu1&, Ying Wang1&, 2023
  • βIV-Spectrin in Cardiac Fibroblasts: Implications for Fibrosis and Therapeutic Targeting in Cardiac Diseases, Xiang W, Zhou N, Li L, Chen F, Li L, Wang Y, 2023
  • Divergent Actions of Myofibroblast and Myocyte β2-Adrenoceptor in Heart Failure and Fibrotic Remodeling, Deng B, Zhang Y, Zhu C, Wang Y, Weatherford E, Xu B, Liu X, Conway SJ, Abel ED, Xiang YK, 2023
  • Monoamine oxidase A and organic cation transporter 3 coordinate intracellular β1AR signaling to calibrate cardiac contractile function, Wang Y, Zhao M, Xu B, Bahriz SMF, Zhu C, Jovanovic A, Ni H, Jacobi A, Kaludercic N, Di Lisa F, Hell JW, Shih JC, Paolocci N, Xiang YK, 2022
  • Monoamine Oxidases Desensitize Intracellular β1AR Signaling in Heart Failure, Wang Y, Zhao M, Shi Q, Xu B, Zhu C, Li M, Mir V, Bers DM, Xiang YK, 2022
  • Intracellular β1-Adrenergic receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility, Wang Y*, Shi Q*, Li M, Zhao M, Reddy GR, Teoh JP, Xu B, Zhu CQ, Ireton KE, Srinivasan S, Chen SL, Gasser PJ, Bossuyt J, Hell JW, Bers DM, Xiang YK, 2020
  • Carvedilol induces biased β1 adrenergic receptor-Nitric oxide synthase 3-cyclic guanylyl monophosphate signaling to promote cardiac contractility, Wang Q, Wang Y, West TM, Liu Y, Reddy GR, Barbagallo F, Xu B, Shi Q, Deng B, Wei W, Xiang YK, 2020
  • GRK5 Controls SAP97-Dependent Cardiotoxic β1 adrenergic receptor-CaMKII signaling in heart failure, Xu B, Li M, Wang Y, Zhao M, Morotti S, Shi Q, Wang Q, Barbagallo F, Teoh JP, Reddy GR, Bayne EF, Liu Y, Shen A, Puglisi JL, Ge Y, Li J, Grandi E, Nieves-Cintron M, Xiang YK, 2020
  • Illuminating cell signaling with genetically encoded FRET biosensors in adult mouse cardiomyocytes, Reddy GR, West TM, Jian Z, Jaradeh M, Shi Q, Wang Y, Chen-Izu Y, Xiang YK, 2018
  • The discovery of a novel inhibitor of apoptotic protease activating factor-1 (Apaf-1) for ischemic heart: synthesis, activity and target identification, Wang Y, Cao Y, Zhu Q, Gu X, Zhu YZ, 2016
  • ZYZ-772 Prevents Cardiomyocyte Injury by Suppressing nox4-derived ROS production and apoptosis, Wang Y, Zhong L, Liu X, Zhu YZ, 2017
  • Apoptotic Protease activating factor-1 inhibitor mitigates myocardial ischemia injury via disturbing procaspase-9 recruitment by Apaf-1, Wang Y, Zhang Q, Zhong L, Lin M, Luo X, Liu S, Xu P, Liu X, Zhu YZ, 2017
  • Neuroprotective Effect of SCM-198 through stabilizing endothelial cell function, Zhang QY, Wang ZJ, Miao L, Wang Y, Chang LL, Guo W, Zhu YZ, 2019
  • Novel Therapeutic effects of leonurine on ischemic stroke: New Mechanisms of BBB Integrity, Zhang QY, Wang ZJ, Sun DM, Wang Y, Xu P, Wu WJ, Liu XH, Zhu YZ, 2017
  • Probing spatiotemporal PKA activity at the ryanodine receptor and SERCA2a nanodomains in cardomyocytes, Xu B, Wang Y, Bahriz SMFM, Zhao M, Zhu C, Xiang YK, 2022
Gpcr Nanodomain Cardiac Physiology Pathology Calcium Signaling Heart Failure Arrhythmias Polypharmacology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.